Excess EDRF/NO, a potentially deleterious condition that may be involved in accelerated atherogenesis and other chronic disease states

General Pharmacology: The Vascular System - Tập 26 - Trang 667-680 - 1995
Francis V. Defeudis1
1Institute for BioScience, 3 Spanish River Road, Grafton, MA 01519, U.S.A. [Tel/Fax: (508) 898-2689]

Tài liệu tham khảo

Aoki, 1990, Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock, Am. J. Physiol., 258, G275 Arnold, 1977, Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations, 74, 3203 Arroyo, 1992, Mutagenicity of nitric oxide and its inhibition by antioxidants, Mutation Res., 281, 193, 10.1016/0165-7992(92)90008-6 Azuma, 1986, Endothelium-dependent inhibition of platelet aggregation, Br. J. Pharmac., 88, 411, 10.1111/j.1476-5381.1986.tb10218.x Bar-Shavit, 1990, Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: Nonenzymatic mode of action, Cell Regul., 1, 453, 10.1091/mbc.1.6.453 Baydoun, 1993, Bacterial endotoxin rapidly stimulates prolonged endothelium-dependent vasodilatation in the rat isolated perfused heart, Br. J. Pharmac., 109, 987, 10.1111/j.1476-5381.1993.tb13718.x Beckman, 1990, Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide, 87, 1620 Boice, 1983, Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU), N. Engl. J. Med., 309, 1079, 10.1056/NEJM198311033091802 Bredt, 1989, Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum, 86, 9030 Bredt, 1992, Nitric oxide, a novel neuronal messenger, Neuron, 8, 3, 10.1016/0896-6273(92)90104-L Brian, 1986, Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta, J. Pharmac. exp. Ther., 237, 608 Cameron, 1979 Carrado, 1992, Mechanism of pain induced by radiocontrast media, Toxic. Lett., 64/65, 739, 10.1016/0378-4274(92)90255-I Challis, 1973, Rapid nitrosation of phenols and its implications for health hazards from dietary nitrites, Nature, 244, 466, 10.1038/244466a0 Challis, 1975, Possible cocarcinogenic effects of coffee constituents, Nature, 254, 532, 10.1038/254532a0 Challis, 1978, Rapid formation of N-nitrosamines from nitrogen oxides under neutral and alkaline conditions, IARC Sci. Publ., 19, 127 Constantinides, 1985, Initiation of a transplantable fibrosarcoma by the synergism of two non-initiators, alpha-tocopherol and soya oil, Virchow's Arch. [A], 405, 285, 10.1007/BF00710065 Dawson, 1991, Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, 88, 6368 Defeudis, 1985, Mechanism of endothelium-dependent vasorelaxation, Med. Hypoth., 17, 363, 10.1016/0306-9877(85)90095-7 Defeudis, 1989, EDRF-update, Drugs Today, 25, 115 Defeudis, 1991, Minireview—Coronary atherosclerosis: Current therapeutic approaches and future trends, Life Sci., 49, 689, 10.1016/0024-3205(91)90101-G Deguchi, 1982, L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells, J. biol. Chem., 257, 10147, 10.1016/S0021-9258(18)33996-6 Drewett, 1994, The family of guanylyl cyclase receptors and their ligands, Endocr. Rev., 15, 135, 10.1210/edrv-15-2-135 Efron, 1991, Nitric oxide generation from l-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis, Surgery, 110, 327 1990 Fagin, 1992, Growth factors, cytokines, and vascular injury, Trends cardiovasc. Med., 2, 90, 10.1016/1050-1738(92)90012-H Furchgott, 1984, Role of endothelium in responses of vascular smooth muscle to drugs, A. Rev. Pharmac. Toxic., 24, 175, 10.1146/annurev.pa.24.040184.001135 Furchgott, 1990, The 1989 Ulf von Euler lecture: Studies in endothelium-dependent vasodilation and the endothelium-derived relaxing factor, Acta physiol. scand., 139, 257, 10.1111/j.1748-1716.1990.tb08923.x Furchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038/288373a0 Furlong, 1987, Endothelium-derived relaxing factor inhibits in vitro platelet aggregation, Br. J. Pharmac., 90, 687, 10.1111/j.1476-5381.1987.tb11221.x Granger, 1981, Superoxide radicals in feline intestinal ischemia, Gastroenterology, 81, 22, 10.1016/0016-5085(81)90648-X Griffith, 1984, The nature of endothelium-derived vascular relaxant factor, Nature, 308, 645, 10.1038/308645a0 Griffiths, 1993, Aminoguanidine selectively inhibits inducible nitric oxide synthase, Br. J. Pharmac., 110, 963, 10.1111/j.1476-5381.1993.tb13907.x Groves, 1992, Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty, Cardiovasc. Res., 26, 615, 10.1093/cvr/26.6.615 Hadden, 1979, Cyclic nucleotides and calcium in lymphocyte regulation and activation, Ann. N.Y. Acad. Sci., 332, 241, 10.1111/j.1749-6632.1979.tb47118.x Halliwell, 1992, Biologically relevant metal ion-dependent hydroxyl radical generation: An update, FEBS Lett., 307, 108, 10.1016/0014-5793(92)80911-Y Hanley, 1985, Growth factors, 315, 14 Hibbs, 1987, Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite, Science, 235, 473, 10.1126/science.2432665 Hirose, 1986, Comparison of the effects of 13 phenolic compounds in induction of proliferative lesions of the forestomach and increase in the labelling indices of the glandular stomach and urinary bladder epithelium of Syrian golden hamsters, Carcinogenesis, 7, 1285, 10.1093/carcin/7.8.1285 Hoffmann, 1986, Carcinogenic agents in snuff, J. natn. Cancer Inst., 76, 435 Hughes, 1990, Evidence that endogenous nitric oxide modulates oedema formation induced by substance P, Eur. J. Pharmac., 191, 481, 10.1016/0014-2999(90)94184-Y Ialenti, 1992, Modulation of acute inflammation by endogenous nitric oxide, Eur. J. Pharmac., 211, 177, 10.1016/0014-2999(92)90526-A Ignarro, 1991, Signal transduction mechanisms involving nitric oxide, Biochem. Pharmac., 41, 485, 10.1016/0006-2952(91)90618-F Ignarro, 1981, Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates, J. Pharmac. exp. Ther., 218, 739 Ignarro, 1987, Endothelium-derived relaxing factor produced and secreted from artery and vein is nitric oxide, 84, 9265 Iida, 1991, Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat, 88, 6560 Ito, 1989, Antioxidants—carcinogenic and chemopreventive properties, Adv. Cancer Res., 53, 247, 10.1016/S0065-230X(08)60283-3 Jakoby, 1982 Joly, 1992, Balloon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries, Circulation Res., 71, 331, 10.1161/01.RES.71.2.331 Julou-Schaeffer, 1991, Activation of the L-arginine-nitric oxide pathway is involved in vascular hyporeactivity induced by endotoxin, J. cardiovasc. Pharmac., 17, S207, 10.1097/00005344-199117003-00038 Kappus, 1992, Tolerance and safety of vitamin E: A toxicological position report, Free Radical Biol. Med., 13, 55, 10.1016/0891-5849(92)90166-E Kato, 1988, Studies on scavengers of active oxygen species. I. Synthesis and biological activity of 2-O-alkylascorbic acids, J. med. Chem., 31, 793, 10.1021/jm00399a019 Khalil, 1992, The quantitative contribution of nitric oxide and sensory nerves to bradykinin-induced inflammation in rat skin microvasculature, Brain Res., 589, 102, 10.1016/0006-8993(92)91167-D Kikugawa, 1988, Formation of a mutagenic diazoquinone by interaction of phenol with nitrite, Food Chem. Toxic., 26, 209, 10.1016/0278-6915(88)90121-4 Kukreja, 1992, The oxygen free radical system: From equations through membrane-protein interactions to cardiovascular injury and protection, Cardiovasc. Res., 26, 641, 10.1093/cvr/26.7.641 Landau, 1994, Percutaneous transluminal coronary angioplasty, New Engl. J. Med., 330, 981, 10.1056/NEJM199404073301407 Leaf, 1990, Nitrate biosynthesis in rats, ferrets, and humans, 11, 855 Lijinsky, 1980, Significance of in vivo formation of N-nitroso compounds, Oncology, 37, 223, 10.1159/000225440 Lijinsky, 1973, Malignant tumours of the liver and lung in rats fed aminopyrine or heptamethyleneimine together with nitrite, Nature, 244, 176, 10.1038/244176a0 Lisak, 1980, Demyelinating diseases of the central nervous system, 78 Marletta, 1988, Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate, Biochemistry, 27, 8706, 10.1021/bi00424a003 Martin, 1992, Inhibition of endothelium-dependent vasorelaxation by arginine analogues: A pharmacological analysis of agonist and tissue dependence, Br. J. Pharmac., 105, 643, 10.1111/j.1476-5381.1992.tb09033.x Mason, 1982, Free radicals in pharmacology and toxicology—Selected topics, Pharmac. Rev., 33, 189 McCall, 1992, Nitric oxide takes centre stage with newly defined roles, Trends Pharmac. Sci., 13, 1, 10.1016/0165-6147(92)90002-N Miki, 1977, Activation of cerebral guanylate cyclase by nitric oxide, Biochem. biophys. Res. Commun., 75, 851, 10.1016/0006-291X(77)91460-7 Mirvish, 1975, Formation of N-nitroso compounds: Chemistry, kinetics, and in vivo occurrence, Toxic. appl. Pharmac., 31, 325, 10.1016/0041-008X(75)90255-0 Mirvish, 1972, Ascorbate-nitrite reaction: Possible means of blocking the formation of carcinogenic N-nitroso compounds, Science, 177, 65, 10.1126/science.177.4043.65 Miwa, 1987, Nitrosation of amines by stimulated macrophages, Carcinogenesis, 8, 955, 10.1093/carcin/8.7.955 Moncada, 1991, Nitric oxide: Physiology, pathophysiology and pharmacology, Pharmac. Rev., 43, 109 Myers, 1990, Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide, Nature, 345, 161, 10.1038/345161a0 Nguyen, 1991, Deamination of nucleic bases by nitric oxide and related compounds, 32, 108 Noack, 1991, Molecular mechanism of nitrovasodilator bioactivation, 37 Norkus, 1986, Inhibitory effect of alpha-tocopherol on the formation of nitrosomorpholine in mice treated with morpholine and exposed to nitrogen dioxide, Carcinogenesis, 7, 357, 10.1093/carcin/7.3.357 Ohshima, 1981, Quantitative estimation of endogenous nitrosation in humans by monitoring N-nitrosoproline excretion in the urine, Cancer Res., 41, 3658 Ohshima, 1982, Monitoring of N-nitrosamino acids excreted in urine and feces of rats as an index for endogenous nitrosation, Carcinogenesis, 3, 115, 10.1093/carcin/3.1.115 Palmer, 1987, Nitric oxide accounts for the biological activity of endothelium derived relaxing factor, Nature, 327, 524, 10.1038/327524a0 Palmer, 1988, Vascular endothelial cells synthesize nitric oxide from l-arginine, Nature, 333, 664, 10.1038/333664a0 Palmer, 1988, l-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation, Biochem. biophys. Res. Commun., 153, 1251, 10.1016/S0006-291X(88)81362-7 Palmer, 1992, The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids, Br. J. Pharmac., 105, 11, 10.1111/j.1476-5381.1992.tb14202.x Parillo, 1990, Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy, Ann. Intern. Med., 113, 227, 10.7326/0003-4819-113-3-227 Petros, 1991, Effect of nitric oxide synthase inhibitors on hypotension and septic shock, Lancet, 338, 1557, 10.1016/0140-6736(91)92376-D Peunova, 1993, Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells, Nature, 364, 450, 10.1038/364450a0 Pfundstein, 1991, The mean daily intake of primary and secondary amines from foods and beverages in West Germany in 1989–1990, Food Chem. Toxic., 11, 733, 10.1016/0278-6915(91)90181-6 Pignatelli, 1982, Catalysis of nitrosation in vitro and in vivo in rats by catechin and resorcinol and inhibition by chlorogenic acid, Carcinogenesis, 3, 1045, 10.1093/carcin/3.9.1045 Pizcueta, 1992, Effect of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension, Br. J. Pharmac., 105, 184, 10.1111/j.1476-5381.1992.tb14233.x Preussmann, 1987, The enigma of the organ-specificity of carcinogenic nitrosamines, Trends Pharmac. Sci., 8, 185, 10.1016/0165-6147(87)90164-7 Pryor, 1981, Mechanisms of nitrogen dioxide reactions: Initiation of lipid peroxidation and the production of nitrous acid, Science, 214, 435, 10.1126/science.214.4519.435 Radomski, 1987, Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin in platelets, Br. J. Pharmac., 92, 181, 10.1111/j.1476-5381.1987.tb11310.x Radomski, 1987, The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium, Biochem. biophys. Res. Commun., 148, 1482, 10.1016/S0006-291X(87)80299-1 Rees, 1990, Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock, Biochem. biophys. Res. Commun., 173, 541, 10.1016/S0006-291X(05)80068-3 Richards, 1991 Roman, 1973, Studies on horseradish peroxidase. XII. A kinetic study of the oxidation of sulfite and nitrite by compounds I and II, Can. J. Chem., 51, 588, 10.1139/v73-089 Ross, 1988, Growth factors in the pathogenesis of atherosclerosis, Acta med. scand., 715, 33 Schmidt, 1992, NO·, CO and ·OH: Endogenous soluble guanylyl cyclase-activating factors, FEBS Lett., 307, 102, 10.1016/0014-5793(92)80910-9 Shibata, 1992, The modifying effects of indomethacin or ascorbic acid on cell proliferation induced by different types of bladder tumor promoters in rat urinary bladder and forestomach mucosal epithelium, Jpn. J. Cancer Res., 83, 31, 10.1111/j.1349-7006.1992.tb02348.x Shimamoto, 1987, A novel active oxygen species scavenger, CV-3611: radical scavenging activity in vitro and inhibition of myocardial derangement in vivo, 153 Spiegelhalder, 1985, In vivo nitrosation of amidopyrine in humans: Use of “ethanol effect” for biological monitoring of N-nitrosodimethylamine in urine, Carcinogenesis, 6, 545, 10.1093/carcin/6.4.545 Spiegelhalder, 1976, Influence of dietary nitrate on nitrite content of human saliva: Possible relevance to in vivo formation of N-nitroso compounds, Food Cosmet. Toxic., 14, 545, 10.1016/S0015-6264(76)80005-3 Steuhr, 1987, Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection or interferon-γ, J. Immun., 139, 518, 10.4049/jimmunol.139.2.518 Stiles, 1979, Dual control of cell growth of somatomedins and platelet-derived growth factor, 76, 1279 Suffredini, 1989, The cardiovascular response of normal humans to the administration of endotoxin, New Engl. J. Med., 321, 280, 10.1056/NEJM198908033210503 Suzuki, 1991, Inhibitory effect of 2-O-octadecylascorbic acid in agglutination assay with concanavalin A: Short-term examination of rat urinary bladder carcinogenesis, Jpn. J. Cancer Res., 82, 386, 10.1111/j.1349-7006.1991.tb01860.x Takahashi, 1992, Measurements of serum levels of nitrate ions in men and women: Implications of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis, J. cardiovasc. Pharmac., 20, S214, 10.1097/00005344-199204002-00061 Tannenbaum, 1991, Inhibition of nitrosamine formation by ascorbic acid, Am. J. clin. Nutr., 53, 247S, 10.1093/ajcn/53.1.247S Tricker, 1992, Secondary amine precursors to nitrosamines in human saliva, gastric juice, blood, urine and feces, Carcinogenesis, 13, 563, 10.1093/carcin/13.4.563 Vallance, 1992, The role of induction of nitric oxide synthesis in the altered responses of jugular veins from endotoxaemic rabbits, Br. J. Pharmac., 106, 459, 10.1111/j.1476-5381.1992.tb14356.x Verbeuren, 1986, Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits, Circulation Res., 58, 552, 10.1161/01.RES.58.4.552 Vita, 1990, Coronary vasomotor response to acetylcholine relates to risk-factors for coronary-artery disease, Circulation, 81, 491, 10.1161/01.CIR.81.2.491 Wagner, 1983, Metabolic fate of an oral dose of 15N-labeled nitrate in humans: Effect of diet supplementation with ascorbic acid, Cancer Res., 43, 1921 Washburn, 1992, Late stroke after carotid endarterectomy: The role of recurrent stenosis, J. vasc. Surg., 15, 1032, 10.1016/0741-5214(92)90460-P Weiner, 1988, Immunotherapy of multiple sclerosis, Ann. Neurol., 23, 211, 10.1002/ana.410230302 Wilensky, 1993, Methods and devices for local drug delivery in coronary and peripheral arteries, Trends cardiovasc. Med., 3, 163, 10.1016/1050-1738(93)90001-M Wink, 1991, DNA deaminating ability and genotoxicity of nitric oxide and its progenitors, Science, 254, 1001, 10.1126/science.1948068 Wright, 1992, Protective and pathological role of nitric oxide in endotoxin shock, Cardiovasc. Res., 26, 48, 10.1093/cvr/26.1.48 Youn, 1991, Trends in shock research: Use of antioxidant therapy in shock and trauma, Circulatory Shock, 35, 245 Young, 1992, The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat, Free Radical Biol. Med., 13, 41, 10.1016/0891-5849(92)90164-C Zingarelli, 1992, Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock, J. cardiovasc. Pharmac., 19, 982, 10.1097/00005344-199206000-00021